Amphiphilic hyper-branched co-polymer nanoparticles for the controlled delivery of anti-tumor agents

Biomaterials

Volumn 31, Issue 28, 2010, Pages 7364-7375

  Miao, Qinghua ^a,b   Xu, Dongxue ^a,b   Wang, Zhi ^b   Xu, Li ^b   Wang, Tiewei ^a   Wu, Yan ^a   Lovejoy, David B ^c   Kalinowski, Danuta S ^c   Richardson, Des R ^c   Nie, Guangjun ^a   Zhao, Yuliang ^a,d  

^a NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^b JILIN UNIVERSITY   (China)

^c UNIVERSITY OF SYDNEY   (Australia)

^d INSTITUTE OF HIGH ENERGY PHYSICS   (China)

Author keywords

Controlled drug release; Cytotoxicity; Drug delivery; Nanoparticle

Indexed keywords

ACIDIC PH; AMPHIPHILICS; ANTI-TUMOR ACTIVITIES; ANTI-TUMOR AGENTS; ANTI-TUMORS; AQUEOUS SOLUTIONS; BIOLOGICAL PROPERTIES; CONCENTRATION-DEPENDENT; CONTROLLED DELIVERY; CONTROLLED DRUG RELEASE; DRUG DELIVERY NANOPARTICLE; IN-VITRO; INTRACELLULAR DELIVERY; LOADING CAPACITIES; MICROSCOPIC OBSERVATIONS; NANOCARRIERS; POLY LACTIDE; THIOSEMICARBAZONES; TUMOR CELLS;

CELL PROLIFERATION; DRUG PRODUCTS; ESTERS; NANOPARTICLES; POLYMERS; TUMORS;

CONTROLLED DRUG DELIVERY;

2 BENZOYLPYRIDINE 4 ETHYL 3 THIOSEMICARBAZONE; ANTINEOPLASTIC AGENT; COPOLYMER; NANOCARRIER; NANOPARTICLE; UNCLASSIFIED DRUG; DRUG CARRIER; POLYMER;

AQUEOUS SOLUTION; ARTICLE; CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENCAPSULATION; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO SELECTION; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; DRUG FORMULATION; MATERIALS TESTING; METABOLISM; PROCEDURES; SYNTHESIS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; HUMANS; MATERIALS TESTING; MOLECULAR STRUCTURE; NANOPARTICLES; POLYMERS;

EID: 77955280542     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.06.012     Document Type: Article

References (40)

1. Jabr-Milane L.S., van Vlerken L.E., Yadav S., Amiji M.M. Multi-functional nanocarriers to overcome tumor drug resistance. Cancer Treat Rev 2008, 34:592-602.
2. Wang X., Yang L., Chen Z.G., Shin D.M. Application of nanotechnology in cancer therapy and imaging. CA Cancer J Clin 2008, 58:97-110.
3. Gao Y., Chen L.L., Gu W.W., Xi Y., Lin L.P., Li Y.P. Targeted nanoassembly loaded with docetaxel improves intracellular drug delivery and efficacy in murine breast cancer model. Mol Pharm 2008, 5:1044-1054.
4. Tang N., Du G., Wang N., Liu C., Hang H., Liang W. Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin. J Natl Cancer Inst 2007, 99:1004-1015.
5. Wang J., Mongayt D., Torchilin V.P. Polymeric micelles for delivery of poorly soluble drugs: preparation and anticancer activity in vitro of paclitaxel incorporated into mixed micelles based on poly(ethylene glycol)-lipid conjugate and positively charged lipids. J Drug Target 2005, 13:73-80.
6. Duncan R. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer 2006, 6:688-701.
7. Kalinowski D.S., Richardson D.R. The evolution of iron chelators for the treatment of iron overload disease and cancer. Pharmacol Rev 2005, 57:547-583.
8. Le N.T., Richardson D.R. The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim Biophys Acta 2002, 1603:31-46.
9. Richardson D.R. Iron chelators as therapeutic agents for the treatment of cancer. Crit Rev Oncol Hematol 2002, 42:267-281.
10. Kalinowski D.S., Yu Y., Sharpe P.C., Islam M., Liao Y.T., Lovejoy D.B., et al. Design, synthesis, and characterization of novel iron chelators: structure-activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agents. J Med Chem 2007, 50:3716-3729.
11. Whitnall M., Howard J., Ponka P., Richardson D.R. A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics. Proc Natl Acad Sci U S A 2006, 103:14901-14906.
12. Yuan J., Lovejoy D.B., Richardson D.R. Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment. Blood 2004, 104:1450-1458.
13. Kataoka K., Harada A., Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 2001, 47:113-131.
14. Torchilin V.P. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release 2001, 73:137-172.
15. Torchilin V.P. Lipid-core micelles for targeted drug delivery. Curr Drug Deliv 2005, 2:319-327.
16. Layre A., Couvreur P., Chacun H., Richard J., Passirani C., Requier D., et al. Novel composite core-shell nanoparticles as busulfan carriers. J Control Release 2006, 111:271-280.
17. Savic R., Luo L., Eisenberg A., Maysinger D. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 2003, 300:615-618.
18. Gao C., Yan D. Hyperbranched polymers: from synthesis to applications. Prog Polym Sci 2004, 29:183-275.
19. Voit B. New developments in hyperbranched polymers. J Polym Sci Part Pol Chem 2000, 38:2505-2525.
20. Li Y.Y., Zhang X.Z., Kim G.C., Cheng H., Cheng S.X., Zhuo R.X. Thermosensitive Y-shaped micelles of poly(oleic acid-Y-N-isopropylacrylamide) for drug delivery. Small 2006, 2:917-923.
21. Tian H.Y., Deng C., Lin H., Sun J.R., Deng M.X., Chen X.S., et al. Biodegradable cationic PEG-PEI-PBLG hyperbranched block copolymer: synthesis and micelle characterization. Biomaterials 2005, 26:4209-4217.
22. Gao C., Xu Y.M., Yan D.Y., Chen W. Water-soluble degradable hyperbranched polyesters: novel candidates for drug delivery?. Biomacromolecules 2003, 4:704-712.
23. Kainthan R.K., Gnanamani M., Ganguli M., Ghosh T., Brooks D.E., Maiti S., et al. Blood compatibility of novel water soluble hyperbranched polyglycerol-based multivalent cationic polymers and their interaction with DNA. Biomaterials 2006, 27:5377-5390.
24. Karger-Kocsis J., Frohlich J., Gryshchuk O., Kautz H., Frey H., Mulhaupt R. Synthesis of reactive hyperbranched and star-like polyethers and their use for toughening of vinylester-urethane hybrid resins. Polymer 2004, 45:1185-1195.
25. Kim H.J., Kwon M.S., Choi J.S., Kim B.H., Yoon J.K., Kim K., et al. Synthesis and characterization of poly(amino ester) for slow biodegradable gene delivery vector. Bioorgan & Med Chem 2007, 15:1708-1715.
26. Kolhe P., Misra E., Kannan R.M., Kannan S., Lieh-Lai M. Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers. Int J Pharm 2003, 259:143-160.
27. Blanco M.D., Alonso M.J. Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres. Eur J Pharm Biopharm 1997, 43:287-294.
28. Jeong B., Bae Y.H., Kim S.W. Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers. J Control Release 2000, 63:155-163.
29. Yang R., Yang S.G., Shim W.S., Cui F.D., Cheng G., Kim I.W., et al. Lung-specific delivery of paclitaxel by chitosan-modified PLGA nanoparticles via transient formation of microaggregates. J Pharma Sci-US 2009, 98:970-984.
30. Jiang M., Wu Y., He Y., Nie J. Micelles formed by self-assembly of hyperbranched poly [(amine-ester)-co-(d, l-lactide)](HPAE-co-PLA) copolymers for protein drug delivery. Polym Int 2009, 58:31-39.
31. Zhang L., Yang M., Wang Q., Li Y., Guo R., Jiang X., et al. 10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in mice. J Control Release 2007, 119:153-162.
32. Kubies D., Rypacek F., Kovarova J., Lednicky F. Microdomain structure in polylactide-block-poly(ethylene oxide) copolymer films. Biomaterials 2000, 21:529-536.
33. Danhier F., Vroman B., Lecouturier N., Crokart N., Pourcelle V., Freichels H., et al. Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel. J Control Release 2009, 140:166-173.
34. Wang Y., Ng Y.W., Chen Y., Shuter B., Yi J., Ding J., et al. Formulation of superparamagnetic iron oxides by nanoparticles of biodegradable polymers for magnetic resonance imaging. Adv Funct Mater 2008, 18:308-318.
35. Mainardes R.M., Evangelista R.C. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int J Pharm 2005, 290:137-144.
36. Allen C., Han J.N., Yu Y.S., Maysinger D., Eisenberg A. Polycaprolactone-b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for dihydrotestosterone. J Control Release 2000, 63:275-286.
37. Anderson R.G.W., Orci L. A view of acidic intracellular compartments. J Cell Biol 1988, 106:539-543.
38. Diwu Z.J., Chen C.S., Zhang C.L., Klaubert D.H., Haugland R.P. A novel acidotropic pH indicator and its potential application in labeling acidic organelles of live cells. Chem Biol 1999, 6:411-418.
39. Chan J.M., Zhang L.F., Yuet K.P., Liao G., Rhee J.W., Langer R., et al. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials 2009, 30:1627-1634.
40. Yuan X.M., Li W., Dalen H., Lotem J., Kama R., Sachs L., et al. Lysosomal destabilization in p53-induced apoptosis. Proc Natl Acad of Sci U S A 2002, 99:6286-6291.